Novel synergistic treatment for depression: involvement of GSK3β-regulated AMPA receptors in the prefrontal cortex of mice
Cerebral Cortex · 2023
DOI: 10.1093/cercor/bhad299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cerebral Cortex, 2023. Verfasst von Lei Guo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, PR China. Hauptthemen laut MEDLINE: Receptors, AMPA, Prefrontal Cortex, Glycogen Synthase Kinase 3 beta, Depression. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Natural Science Funds for Distinguished Young Scholar of Zhejiang, National Natural Science Foundation of China, Municipal Key Research and Development Program of Ningbo.
Themen: Depression
Abstract (Originalsprache)
Previous evidence has suggested a vital role of glycogen synthase kinase 3β-mediated α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors trafficking in depression. Considering the antidepressant effect of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors activation in the prefrontal cortex, we hypothesized that glycogen synthase kinase 3β-induced alterations in α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors function in the prefrontal cortex participate in depression. Herein, we confirmed that the levels of phosphorylated glycogen synthase kinase 3β and GluA1, the latter being a subunit of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors, were decreased in the prefrontal cortex of the chronic social defeat stress model mice presenting with depressive-like behaviors. We then found that a glycogen synthase kinase 3β (p.S9A) point mutation downregulated GluA1 and induced depressive-like behaviors in mice, whereas an agonist of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors, PF-4778574 (2 mg/kg) did not reversed the molecular changes. On the other hand, the antidepressant effect of PF-4778574 was dose dependent, and the single administration of PF-4778574 at a lower dose (0.5 mg/kg) or of the glycogen synthase kinase 3β inhibitor SB216763 (5 and 10 mg/kg) did not evoke an antidepressant effect. In contrast, co-treatment with PF-4778574 (0.5 mg/kg) and SB216763 (10 mg/kg) led to antidepressant effects similar to those of PF-4778574 (2 mg/kg). Our results suggest that glycogen synthase kinase 3β-induced α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors dysfunction in the prefrontal cortex is one of the key mechanisms of depression, and the combination of a lower dose of PF-4778574 with SB216763 shows potential as a novel synergistic treatment for depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, PR China.
- School of Basic Medical Science, Health Science Center, Ningbo University, Ningbo, Zhejiang 315211, PR China.
- Department of Psychiatry, Ningbo Kangning Hospital, Ningbo, Zhejiang 315201, PR China.
Förderung
- Natural Science Funds for Distinguished Young Scholar of Zhejiang
- National Natural Science Foundation of China
- Municipal Key Research and Development Program of Ningbo
- Ningbo Natural Science Foundation
Zitieren
APA
Guo, L., Wang, S., Tian, H., Shang, M., Xu, J., & Wang, C. (2023). Novel synergistic treatment for depression: involvement of GSK3β-regulated AMPA receptors in the prefrontal cortex of mice. Cerebral Cortex. https://doi.org/10.1093/cercor/bhad299
Vancouver
Guo L, Wang S, Tian H, Shang M, Xu J, Wang C. Novel synergistic treatment for depression: involvement of GSK3β-regulated AMPA receptors in the prefrontal cortex of mice. Cerebral Cortex. 2023. doi:10.1093/cercor/bhad299
BibTeX
@article{Guo2023,
author = {Guo, Lei and Wang, Shuzhuo and Tian, Haihua and Shang, Mengyuan and Xu, Jia and Wang, Chuang},
title = {Novel synergistic treatment for depression: involvement of GSK3β-regulated AMPA receptors in the prefrontal cortex of mice},
journal = {Cerebral Cortex},
year = {2023},
doi = {10.1093/cercor/bhad299}
}
EUVIMED